Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
Determine safety and effectiveness of the technique using autologous stem cells in the treatment of urinary incontinence in one male subject.
Autologous stem cells will be obtained from the subject by needle biopsy, sent to a lab for multiplication and after about 6 weeks time will be injected into the subjects urethra.
Inclusion Criteria:
Exclusion Criteria:
- does not meet inclusion criteria, gender and age limit